Brief: Basilea: Prelim Operating Profit For 2022 Significantly Above Guidance

Basilea Pharmaceutica AG, Allschwil

24/01/2023 06:18

Jan 24 (Reuters) - Basilea Pharmaceutica Ag  BSLN.S :
    * BASILEA REPORTS PRELIMINARY OPERATING PROFIT FOR 2022,
SIGNIFICANTLY ABOVE GUIDANCE
    * EXPECTS TO HAVE ACHIEVED AN OPERATING PROFIT OF
APPROXIMATELY
CHF 18 MILLION FOR FINANCIAL YEAR 2022
    * EXPECTS TO REPORT A NET PROFIT
    * BASILEA HAD PREVIOUSLY GUIDED FOR AN OPERATING LOSS FOR
2022 OF
CHF 10 MILLION TO 15 MILLION
    * UNAUDITED TOTAL REVENUE FOR 2022 IS EXPECTED TO AMOUNT TO
APPROXIMATELY CHF 148 MILLION, EXCEEDING PREVIOUS FULL-YEAR 2022
GUIDANCE OF CHF 116 MILLION TO 122 MILLION

Further company coverage:  BSLN.S 
 (Reporting by Berlin Newsroom)
 ((berlin.newsroom@thomsonreuters.com;))